NMPA Reform and the 57% Beauty OEM Opportunity

China's National Medical Products Administration (NMPA) is the authority that decides whether a cosmetic product may be manufactured, imported, or sold in mainland China. Think of it as the Chinese counterpart to the EU's cosmetic framework and the US FDA's cosmetic oversight, except that NMPA also runs the registration and filing system every product must clear before it reaches a shelf. In the last few years NMPA has rebuilt that system, and for any export or China-facing beauty brand the changes are now part of the factory-selection process, not just a regulatory footnote.

What the NMPA reform actually changed

The reform is best understood as three shifts that together changed who carries the compliance burden.

Cosmetics were formally separated from drugs

Under the old regime, cosmetics sat in a regulatory grey zone close to pharmaceuticals, which pushed every product toward slow, drug-like approval. The new framework recognises cosmetics as their own category with proportionate oversight. That single change is what made faster, filing-based market entry possible and unlocked the contract-manufacturing boom that followed.

Special and regular filing replaced blanket approval

Products are now split into two tracks. "Special cosmetics" - hair dyes, perming, depilatory, whitening, sun protection, and certain claims-driven items - still require NMPA registration before sale. Everything else falls into "regular cosmetics," which use a notification (filing) route that is far quicker. A new brand's speed-to-market therefore depends heavily on which track its hero product sits in, and on how cleanly the manufacturer prepares the dossier.

Safety assessment became the brand's own responsibility

Perhaps the most important change: the burden of safety proof moved from the regulator to the registrant. The brand (or its China responsible person) must hold a signed safety assessment report, supported by ingredient data, stability testing, and challenge testing for preservative systems. The factory no longer "gets you approved" - it supplies the evidence, and the brand owns the submission. This is why a manufacturer's documentation discipline now matters as much as its production line.

Why about 57% of domestic beauty brands now run on OEM/ODM

Industry sourcing data consistently shows that roughly 57% of domestic Chinese beauty brands do not manufacture their own formulas in-house; they rely on OEM or ODM partners. The reform accelerated that already-strong trend for four concrete reasons.

• Lower entry cost. Filing is faster than old-style approval, but it still demands a tested formula, stability data, and a safety dossier. Renting that capability from a qualified factory beats building a lab from scratch.
• Speed. ODM partners already hold validated base formulations and can adapt a variant in weeks, letting a brand ride a trend before the window closes.
• Shared compliance risk. With safety assessment resting on the brand, working with a factory that already produces NMPA-filed products reduces the chance of a rejected submission.
• Capital efficiency. Emerging brands funded by venture or retail capital prefer to spend on marketing and distribution, not on brick-and-mortar plants. OEM/ODM turns fixed cost into variable cost.

The 57% figure is not a ceiling. As efficacy-claim rules tighten, more brands are expected to lean on manufacturers that can supply the underlying test data, not just the bottle.

What the reform means for a new brand choosing a manufacturer

For a founder evaluating factories today, the reform changes the question from "can they make it?" to "can they help me stay filed?"

Track fit matters more than price

If your hero product is a whitening serum or an SPF, you are in the special-cosmetics track and need a manufacturer comfortable with full registration. A cheap regular-filing factory may quietly stall your launch. Match the factory's track record to your product category before negotiating cost.

Documentation is the real deliverable

Ask to see a sample safety assessment report and a sample filing record. A serious OEM/ODM partner treats these as core deliverables, not afterthoughts. If a factory cannot show you a clean, recent NMPA filing for a product like yours, that is a red flag regardless of price.

The responsible-person gap

Foreign and many domestic brands must appoint a China responsible person to hold the dossier and answer regulator queries. Some manufacturers offer this as a service; others expect you to source it. Clarify who owns that role early, because an unanswered NMPA query can freeze a product.

How to pick an NMPA-compliant OEM partner

Use this checklist when you shortlist factories.

• Verify the license. Confirm the factory holds a valid cosmetics production license and, ideally, GMP-aligned certification such as ISO 22716. Cross-check the license number where NMPA publishes it.
• Ask for filed-product references. Request two or three products in your category that the factory has already taken through NMPA filing or registration, with the brand's permission to reference them.
• Inspect the testing capability. Does the factory run stability, microbiological, and challenge testing in-house, or outsource it? In-house testing usually means faster iterations and tighter data control.
• Map the claim support. For every efficacy claim you plan - moisturising, soothing, brightening - confirm the factory can supply the substantiation method (consumer test, instrumental measurement, or clinical) the rules require.
• Clarify ownership of the dossier. Get in writing who prepares, submits, and owns the safety assessment and filing, and what happens if a submission is rejected.
• Check restricted-ingredient discipline. A good partner keeps a live cross-check against NMPA positive and negative lists and flags banned or capped materials before formulation, not after.

The reform did not make compliance optional - it moved compliance upstream, into the formula and the dossier. The right factory is the one whose paperwork is as reliable as its production.

Platforms such as QuickOEM exist to shorten this search, matching brands with vetted factories that already hold NMPA filing experience across skincare, makeup, and masks. The practical takeaway is simple: treat regulatory capability as a primary selection criterion, because under the new NMPA regime the manufacturer you choose is also your compliance partner.